Skip to content

Valuating the effect of inofolic supplementation on depression in Poly cystic ovarian syndrome women

Evaluating the effect of inofolic supplementation on depression in Polycystic ovarian syndrome women with mild to moderate depression

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20110731007165N11
Enrollment
106
Registered
2020-12-25
Start date
2021-01-09
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression. Other depressive episodes

Interventions

Intervention 1: Intervention group: Inofolic Powder twice daily for 12 weeks. Intervention 2: Control group: Without intervention.

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 18-40 years With mild to moderate depression BMI <= 30

Exclusion criteria

Exclusion criteria: Smoking Taking folate supplements in the last 3 months Metabolic and thyroid disorders Hyperprolactinemia Hypercortisolemia Severe depression Use of drugs affecting the nervous system (such as antidepressants and anti-anxiety drugs) Insulin use Lack of blood sugar control Intense physical activity Pregnancy Lactation History of mental health problems in first degree relatives, Other diseases in addition to depression

Design outcomes

Primary

MeasureTime frame
Changes in the level of depression. Timepoint: Before and after intervention. Method of measurement: Hamilton Depression Rating Scale (HDRS).

Secondary

MeasureTime frame
The blood tests for LDH,HDL,Total cholesterol ,TG, BMI, waist hip ratio , fasting glucose and insulin. Timepoint: Before and after the intervention. Method of measurement: The blood test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Ladan Kashani

Tehran University of Medical Sciences

Kashani_ladan@tums.ac.ir+98 21 7788 3195

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026